Permanent pacemaker-induced superior vena cava syndrome: successful treatment by endovascular stent.
The use of metallic stents in the management of benign and malignant superior vena cava syndrome (SVCS) is well documented. Symptomatic stenosis or occlusion of the SVC is a rare complication of a transvenous permanent pacemaker implant. Suggested treatments have included anticoagulation therapy, thrombolysis, balloon angioplasty and surgery. More recently, endovascular stenting has evolved as an attractive alternative but the data available in the literature are limited. We describe a case in which venous stenting with a Wallstent endoprosthesis was used successfully. The patient remains symptom free and with normal pacemaker function 36 months later.
Lanciego
Carlos
C
Unit of Interventional Radiology, Hospital Virgen de la Salud, Complejo Hospitalario de Toledo, Toledo, Spain. clanciego@eresmas.com
Rodriguez
Mario
M
Rodriguez
Adela
A
Carbonell
Miguel A
MA
García
Lorenzo García
LG
D000368:Aged; D005260:Female; D006801:Humans; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D015641:Radiography, Interventional; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome